HP3- INCORPORATING CLINICAL OUTCOMES AND ECONOMIC CONSEQUENCES INTO DRUG FORMULARY DECISIONS- EVALUATION OF 30 MONTHS OF EXPERIENCE
Sep 1, 2001, 00:00 AM
10.1046/j.1524-4733.2001.40201-15.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71126-3/fulltext
Section Title :
Section Order :
15
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71126-3&doi=10.1046/j.1524-4733.2001.40201-15.x